本章参考文献
［1］Sullivan，P.F.，Kendler，K.S.and Neale，M.C.Schizophrenia as a complex trait：Evidence from ameta-analysis of twin studies［J］.Arch Gen Psychiatry，2003，60（12）：1187－1192.
［2］Craddock，N.，O'Donovan，M.C.and Owen，M.J.The genetics of schizophrenia and bipolar disorder：Dissecting psychosis［J］.JMed Genet，2005，42（3）：193－204.
［3］O'Donovan，M.C.，Craddock，N.J.and Owen，M.J.Genetics of psychosis：Insights from views across the genome［J］.Hum Genet，2009，126（1）：3－12.
［4］Foley，C.，Corvin，A.and Nakagome，S.Genetics of schizophrenia：Ready to translate？［J］.Current Psychiatry Reports，2017，19（9）：61.
［5］Matheson，S.L.，Shepherd，A.M.，Pinchbeck，R.M.，et al.Childhood adversity in schizophrenia：A systematic meta-analysis［J］.Psychological Medicine，2013，43（2）：225－238.
［6］Cantorgraae，E.and Selten，J.P.Schizophrenia andmigration：Ameta-analysis and review［J］.American Journal of Psychiatry，2005，162（1）：12.
［7］Tandon，R.，Keshavan，M.S.and Nasrallah，H.A.Schizophrenia，“just the facts”whatwe know in 2008.2.Epidemiology and etiology［J］.Schizophrenia Research，2008，106（2）：89－107.
［8］Miyamoto，S.，Miyake，N.，Jarskog，L.F.，et al.Pharmacological treatment of schizophrenia：A critical review of the pharmacology and clinical effects of currentand future therapeutic agents［J］.Molecular Psychiatry，2012，17（12）：1206－1227.
［9］Stefan，L.，Andrea，C.，Loukia，S.，et al.Comparative efficacy and tolerability of15 antipsychotic drugs in schizophrenia：A multiple-treatments meta-analysis［J］.Lancet，2013，382：951－962.
［10］Jari，T.，Jouko，L.N.，Kristian，W.，et al.11-year follow-up of mortality in patients with schizophrenia：A population-based cohort study（FIN11 study）［J］.Lancet，2009，374：620－627.
［11］Alexander，K.，Sean，H.and Kari，S.Human genetics as a foundation for innovative drug development［J］.Nature Biotechnology，2013，31（11）：975－978.
［12］Nioi，P.，Sigurdsson，A.，Thorleifsson，G.，et al.Variant ASGR1 associated with a reduced risk of coronary artery disease［J］.New England Journal of Medicine，2016，374（22）：2131.
［13］Danielle，W.，Jacqueline，M.A.，Joannella，M.，et al.The NHGRI GWAS Catalog，a curated resource of SNP-trait associations［J］.Nucleic Acids Research，2014，42（Database issue）：1001－1006.
［14］O'Donovan，M.C.，Craddock，N.，Norton，N.，et al.Identification of loci associated with schizophrenia by genome-wide association and follow-up［J］.Nat Genet，2008，40（9）：1053－1055.
［15］Riley，B.，Thiselton，D.，Maher，B.S.，et al.Replication of association between schizophrenia and ZNF804A in the Irish case-control study of schizophrenia sample［J］.Mol Psychiatry，2010，15（1）：29－37.
［16］Steinberg，S.，Mors，O.，Borglum，A.D.，et al.Expanding the range of ZNF804A variants conferring risk of psychosis［J］.Mol Psychiatry，2011，16（1）：59－66.
［17］Williams，H.J.，Norton，N.，Dwyer，S.，et al.Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder［J］.Mol Psychiatry，2011，16（4）：429－441.
［18］Stefansson，H.，Ophoff，R.A.，Steinberg，S.，et al.Common variants conferring risk of schizophrenia［J］.Nature，2009，460：744－747.
［19］Williams，H.J.，Craddock，N.，Russo，G.，et al.Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date crosstraditional diagnostic boundaries［J］.Hum Mol Genet，2011，20（2）：387－391.
［20］Purcell，S.M.，Wray，N.R.，Stone，J.L.，et al.Common polygenic variation contributes to risk of schizophrenia and bipolar disorder［J］.Nature，2009，460：748－752.
［21］Shi，J.，Levinson，D.F.，Duan，J.，et al.Common variants on chromosome 6p22.1 are associated with schizophrenia［J］.Nature，2009，460：753－757.
［22］Ferreira，M.A.，O'Donovan，M.C.，Meng，Y.A.，et al.Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder［J］.Nat Genet，2008，40（9）：1056－1058.
［23］Green，E.K.，Grozeva，D.，Jones，I.，et al.The bipolar disorder risk allele at CACNA1C also confers risk of recurrentmajor depression and of schizophrenia［J］.Mol Psychiatry，2010，15（10）：1016－1022.
［24］Mcmahon，F.J.，Akula，N.，Schulze，T.G.，et al.Meta-analysis of genome-wide association data identifies a risk locus formajormood disorders on 3p21.1［J］.Nat Genet，2010，42（2）：128－131.
［25］Doherty，J.L.，O'Donovan，M.C.and Owen，M.J.Recent genomic advances in schizophrenia［J］.Clin Genet，2012，81（2）：103－109.
［26］Lohoff，F.W.Overview of the genetics of major depressive disorder［J］.Curr Psychiatry Rep，2010，12（6）：539－546.
［27］Elodie，D.，Ripke，S.，Neale，B.M.，et al.Biological insights from 108 schizophrenia-associated genetic loci［J］.Nature，2014，511：421－427.
［28］O'Dushlaine，C.，Rossin，L.，Lee，P.H.，et al.Psychiatric genome-wide association study analyses implicate neuronal，immune and histone pathways［C］.2015，18（2）：199－209.
［29］Corvin，A.and Morris，D.W.Genome-wide association studies：Findings at the major histocompatibility complex locus in psychosis［J］.Biological Psychiatry，2014，75（4）：276－283.
［30］Jianxin，S.，Levinson，D.F.，Jubao，D.，et al.Common variants on chromosome 6p22.1 are associated with schizophrenia［J］.Nature，2009，460：753.
［31］Consortium，I.S.G.C.Genome-wide association study implicates HLA-C*01：02 as a risk factor at the major histocompatibility complex locus in schizophrenia［J］.Biological Psychiatry，2012，72（8）：620－628.
［32］Swami，M.New from NPG：Genome-wide association study identifies five new schizophrenia loci［J］.Nature Medicine，2011，17（10）：1199.
［33］Morris，D.W.，Pearson，R.D.，Cormican，P.，et al.An inherited duplication at the gene p21 Protein-Activated Kinase 7（PAK7）is a risk factor for psychosis［J］.Human Molecular Genetics，2014，23（12）：3316－3326.
［34］Sekar，A.，Bialas，A.R.，De，R.H.，et al.Schizophrenia risk from complex variation of complement component4［J］.Nature，2016，530：177－183.
［35］Sekar，A.，Bialas，A.R.，Rivera，H.D.，et al.Schizophrenia risk from complex variation of complement component 4［J］.Nature，2016，530：177－183.
［36］Po-Ru，L.，Gaurav，B.，Alexander，G.，et al.Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis［J］.Nature Genetics，2015，47（12）：1385－1392.
［37］Pharoah，P.D.P.，Antonis，A.，Martin，B.，et al.Polygenic susceptibility to breast cancer and implications for prevention［J］.Nature Genetics，2002，31（1）：33.
［38］Chatterjee，N.，Shi，J.and García-Closas，M.Developing and evaluating polygenic risk predictionmodels for stratified disease prevention［J］.Nature ReviewsGenetics，2016，17（7）：392.
［39］Ripke，S.，Sanders，A.R.，Kendler，K.S.，et al.Genome-wide association study identifies five new schizophrenia loci［J］.Nature Genetics，2011，43（10）：969－976.
［40］Jian，Y.，Beben，B.，Mcevoy，B.P.，et al.Common SNPs explain a large proportion of the heritability for human height［J］.Nature Genetics，2010，42（7）：565－569.
［41］John，I.，Lars，F.，Rivera，M.N.，et al.Detection of large-scale variation in the human genome［J］.Nature Genetics，2004，36（9）：949－951.
［42］Sebat，J.，Lakshmi，B.，Troge，J.，et al.Large-scale copy number polymorphism in the human genome［J］.Science，2004，305：525－528.
［43］Malhotra，D.and Sebat，J.CNVs：Harbingers of a rare variant revolution in psychiatric genetics［J］.Cell，2012，148（6）：1223－1241.
［44］Pulver，A.E.，Nestadt，G.，Goldberg，R.，et al.Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives［J］.Journal of Nervous＆Mental Disease，1994，182（8）：476－478.
［45］Walsh，T.，Mcclellan，J.M.，Mccarthy，S.E.，et al.Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia［J］.Science，2008，320：539－543.
［46］Stefansson，H.，Rujescu，D.，Cichon，S.，et al.Large recurrent microdeletions associated with schizophrenia［J］.Nature，2008，455：232－236.
［47］Mccarroll，S.A.Extending genome-wide association studies to copy-number variation［J］.Hum Mol Genet，2008，17（R2）：R135－R142.
［48］Cohen，J.Virology.Chemokine gene number tied to HIV susceptibility，but with a twist［J］.Science，2005，307：23－24.
［49］Willcocks，L.C.，Lyons，P.A.，Clatworthy，M.R.，et al.Copy number of FCGR3B，which is associated with systemic lupus erythematosus，correlates with protein expression and immune complex uptake［J］.JExp Med，2008，205（7）：1573－1582.
［50］Bentley，R.W.，Pearson，J.，Gearry，R.B.，et al.Association of higher DEFB4 genomic copy number with Crohn's disease［J］.Am J Gastroenterol，2010，105（2）：354－359.
［51］Chubb，J.E.，Bradshaw，N.J.，Soares，D.C.，et al.The DISC locus in psychiatric illness［J］.Mol Psychiatry，2008，13（1）：36－64.
［52］Ousley，O.，Rockers，K.，Dell，M.L.，et al.A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome：Implications for clinical evaluation and treatment［J］.Curr Psychiatry Rep，2007，9（2）：148－158.
［53］Owen，M.J.，Craddock，N.and O'Donovan，M.C.Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia［J］.Arch Gen Psychiatry，2010，67（7）：667－673.
［54］Sebat，J.，Levy，D.L.and Mccarthy，S.E.Rare structural variants in schizophrenia：One disorder，multiple mutations；one mutation，multiple disorders［J］.Trends Genet，2009，25（12）：528－535.
［55］Walsh，T.，Mcclellan，J.M.，Mccarthy，S.E.，et al.Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia［J］.Science，2008，320：539－543.
［56］International Schizophrenia Consortium.Rare chromosomal deletions and duplications increase risk of schizophrenia［J］.Nature，2008，455：237－241.
［57］Xu，B.，Roos，J.L.，Levy，S.，et al.Strong association of de novo copy number mutations with sporadic schizophrenia［J］.Nat Genet，2008，40（7）：880－885.
［58］Kirov，G.，Grozeva，D.，Norton，N.，et al.Support for the involvementof large copy number variants in the pathogenesis of schizophrenia［J］.Hum Mol Genet，2009，18（8）：1497－1503.
［59］Vassos，E.，Collier，D.A.，Holden，S.，et al.Penetrance for copy number variants associated with schizophrenia［J］.Hum Mol Genet，2010，19（17）：3477－3481.
［60］Insel，T.R.Rethinking schizophrenia［J］.Nature，2010，468：187－193.
［61］Prince，M.，Patel，V.，Saxena，S.，et al.No health withoutmental health［J］.Lancet，2007，370：859－877.
［62］Badner，J.A.and Gershon，E.S.Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia［J］.Molecular Psychiatry，2002，7（4）：405.
［63］Harrison，P.J.and Weinberger，D.R.Schizophrenia genes，gene expression，and neuropathology：On the matter of their convergence［J］.Molecular Psychiatry，2005，10（1）：40.
［64］Lewis，C.M.，Levinson，D.F.，Wise，L.H.，et al.Genome scan meta-analysis of schizophrenia and bipolar disorder，Part II：Schizophrenia［J］.The American Journal of Human Genetics，2003，73（1）：34－48.
［65］Munafo，M.R.，Thiselton，D.L.，Clark，T.G.，et al.Association of the NRG1 gene and schizophrenia：A meta-analysis［J］.Molecular Psychiatry，2006，11（6）：539.
［66］Ng，M.Y.，Levinson，D.F.，Faraone，S.V.，et al.Meta-analysis of 32 genomewide linkage studies of schizophrenia［J］.Molecular Psychiatry，2009，14（8）：774.
［67］O'Donovan，M.C.，Craddock，N.，Norton，N.，et al.Identification of loci associated with schizophrenia by genome-wide association and follow-up［J］.Nature Genetics，2008，40（9）：1053.
［68］International，S.C.Common polygenic variation contributes to risk of schizophrenia and bipolar disorder［J］.Nature，2009，460：748.
［69］Ripke，S.，Sanders，A.R.，Kendler，K.S.，et al.Genome-wide association study identifies five new schizophrenia loci［J］.Nature Genetics，2011，43（10）：969.
［70］Shi，J.，Levinson，D.F.，Duan，J.，et al.Common variants on chromosome 6p22.1 are associated with schizophrenia［J］.Nature，2009，460：753.
［71］Stefansson，H.，Ophoff，R.A.，Steinberg，S.，et al.Common variants conferring risk of schizophrenia［J］.Nature，2009，460：744.
［72］Bassett，A.S.，Scherer，S.W.and Brzustowicz，L.M.Copy number variations in schizophrenia：Critical review and new perspectives on concepts of genetics and disease［J］.American Journal of Psychiatry，2010，167（8）：899－914.
［73］Stefansson，H.，Rujescu，D.，Cichon，S.，et al.Large recurrent microdeletions associated with schizophrenia［J］.nature，2008，455：232.
［74］International，S.C.Rare chromosomal deletions and duplications increase risk of schizophrenia［J］.Nature，2008，455：237.
［75］Sullivan，P.F.，Daly，M.J.，O'Donovan，M.Genetic architectures of psychiatric disorders：The emerging picture and its implications［J］.Nature Reviews Genetics，2012，13（8）：537.
［76］Karayiorgou，M.，Simon，T.J.and Gogos，J.A.22q11.2 microdeletions：Linking DNA structural variation to brain dysfunction and schizophrenia［J］.Nature Reviews Neuroscience，2010，11（6）：402.
［77］Mccarthy，S.E.，Makarov，V.，Kirov，G.，et al.Microduplications of16p11.2 are associated with schizophrenia［J］.Nat Genet，2009，41（11）：1223－1227.
［78］Kirov，G.，Pocklington，A.J.，Holmans，P.，et al.De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia［J］.Molecular Psychiatry，2012，17（2）：142.
［79］Stone，J.L.，Donovan，M.C.，Gurling，H.，et al.Rare chromosomal deletions and duplications increase risk of schizophrenia［J］.Nature，2008，455：237－241.
［80］Marshall，C.R.，Howrigan，D.P.，Merico，D.，et al.Contribution of copy number variants to schizophrenia from a genome-wide study of 41，321 subjects［J］.Nature Genetics，2017，49（4）：27－35.
［81］Hreinn，S.，Dan，R.，Sven，C.，et al.Large recurrent microdeletions associated with schizophrenia［J］.Nature，2008，455：232－236.
［82］Rees，E.，Kendall，K.，Pardiñas，A.F.，et al.Analysis of intellectual disability copy number variants for association with schizophrenia［J］.Jama Psychiatry，2016，26（1）：963－969.
［83］Kirov，G.，Pocklington，A.J.，Holmans，P.，et al.De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia［J］.Molecular Psychiatry，2012，17（2）：142－153.
［84］Kirov，G.CNVs in neuropsychiatric disorders［J］.Human Molecular Genetics，2015，24（r1）：R45.
［85］Morris，D.W.，Pearson，R.D.，Cormican，P.，et al.An inherited duplication at the gene p21 Protein-Activated Kinase 7（PAK7）is a risk factor for psychosis［J］.Human Molecular Genetics，2014，23（12）：3316－3326.
［86］Dan，R.，Ingason，A.，Cichon，S.，et al.Disruption of the neurexin 1 gene is associated with schizophrenia［J］.Human Molecular Genetics，2009，18（5）：988－996.
［87］Rees，E.，Walters，J.T.R.，Chambert，K.D.，et al.CNV analysis in a large schizophrenia sample implicates deletions at16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1［J］.Human Molecular Genetics，2014，23（6）：1669－1676.
［88］Kirov，G.，Rees，E.，Walters，J.T.，et al.The penetrance of copy number variations for schizophrenia and developmental delay［J］.Biological Psychiatry，2014，75（5）：378－385.
［89］Tansey，K.E.，Rees，E.，Linden，D.E.，et al.Common alleles contribute to schizophrenia in CNV carriers［J］.Mol Psychiatry，2016，21（8）：1085－1089.
［90］Liu，P.，Carvalho，C.M.，Hastings，P.J.，et al.Mechanisms for recurrent and complex human genomic rearrangements［J］.Current Opinion in Genetics＆Development，2012，22（3）：211－220.
［91］Macarthur，D.G.，Balasubramanian，S.，Frankish，A.，et al.A systematic survey of loss-of-function variants in human protein-coding genes［J］.Science，2012，335：823－828.
［92］Reedik，M.G.，Asimit，J.L.，Day-Williams，A.G.，et al.Genome-wide association analysis of imputed rare variants：Application to seven common complex diseases［J］.Genetic Epidemiology，2012，36（8）：785－796.
［93］De，L.J.，Willemsen，M.H.，van Bon，B.W.，et al.Diagnostic exome sequencing in persons with severe intellectual disability［J］.Child Care Health＆Development，2013，39（2）：301.
［94］Anita，R.，Dagmar，W.，Elisabeth，G.，et al.Range ofgeneticmutations associated with severe non-syndromic sporadic intellectual disability：An exome sequencing study［J］.Lancet，2012，380：1674－1682.
［95］O.Roak，B.J.，Vives，L.，Fu，W.，et al.Multiplex targeted sequencing identifies recurrentlymutated genes in autism spectrum disorders［J］.Science，2012，338：1619－1622.
［96］Rubeis，S.D.，He，X.，Goldberg，A.P.，et al.Synaptic，transcriptional，and chromatin genes disrupted in autism［J］.Nature，2014，515：209－215.
［97］Consortium，E.，Project，E.P.G.，Allen，A.S.，et al.De novo mutations in epileptic encephalopathies［J］.Nature，2013，501：217.
［98］Singh，T.，Kurki，M.I.，Curtis，D.，et al.Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders［J］.Nature Neuroscience，2016，19（4）：571.
［99］Zuk，O.，Schaffner，S.F.，Samocha，K.，et al.Searching formissing heritability：Designing rare variant association studies［J］.Proc Natl Acad Sci USA，2014，111（4）：455－464.
［100］Purcell，S.M.，Moran，J.L.，Fromer，M.，et al.A polygenic burden of rare disruptivemutations in schizophrenia［J］.Nature，2014，506：185－190.
［101］Fromer，M.，Pocklington，A.J.，Kavanagh，D.H.，et al.De novo mutations in schizophrenia implicate synaptic networks［J］.Nature，2014，506：179－184.
［102］Iossifov，I.，O'Roak，B.J.，Sanders，S.J.，et al.The contribution of de novo codingmutations to autism spectrum disorder［J］.Nature，2011，515：216－221.
［103］Genovese，G.，Fromer，M.，Stahl，E.A.，et al.Increased burden of ultra-rare protein-altering variants among 4，877 individuals with schizophrenia［J］.Nature Neuroscience，2016，19（11）：1433.
［104］Akil，H.，Brenner，S.，Kandel，E.，et al.Medicine.The future of psychiatric research：Genomes and neural circuits［J］.Science，2010，327：1580－1581.
［105］Corvin，A.and Sullivan，P.F.What next in schizophrenia genetics for the psychiatric genomics consortium？［J］.Schizophrenia Bulletin，2016，42（3）：538.
［106］O'Byrne，J.J.，Lynch，S.A.，Treacy，E.P.，et al.Unexplained developmental delay／learning disability：Guidelines for best practice protocol for first line assessment and genetic／metabolic／radiological investigations［J］.Irish Journal of Medical Science（1971－ ），2015，185（1）：1－8.
［107］Schaefer，G.B.，Mendelsohn，N.J.and Committee，G.Clinical genetics evaluation in identifying the etiology of autism spectrum disorders：2013 guideline revisions［J］.Genetics in Medicine Official Journal of the American College of Medical Genetics，2008，10（4）：301－305.
［108］Kendall，K.M.，Rees，E.，Escottprice，V.，et al.Cognitive performance among carriers of pathogenic copy number variants：Analysis of 152，000 UK biobank subjects［J］.Biological Psychiatry，2017，82（2）：103－110.
［109］Stefansson，H.，Meyerlindenberg，A.，Steinberg，S.，et al.CNVs conferring risk of autism or schizophrenia affect cognition in controls［J］.Nature，2014，505：361－366.
［110］Miles，J.H.，Takahashi，T.N.，Bagby，S.，et al.Essential versus complex autism：Definition of fundamental prognostic subtypes［J］.American Journal of Medical Genetics Part A，2010，135A（2）：171－180.
［111］Rajarajan，P.，Gil，S.E.，Brennand，K.J.，et al.Spatial genome organization and cognition［J］.Nature Reviews Neuroscience，2016，17（11）：681－691.
［112］Le，C.，F.Ann，R.，David，C.，et al.Multiplex genome engineering using CRISPR／Cas systems［J］.Science，2015，1239（11）：197.
［113］Han，K.，Jeng，E.E.，Hess，G.T.，et al.Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions［J］.Nature Biotechnology，2017，35（5）：463.
［114］Lee，I.S.，Carvalho，C.M.，Douvaras，P.，et al.Characterization ofmolecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patientderived hiPSC neural cells［J］.Npj Schizophr，2015，1（1）：15019.
［115］Wen，Z.，Nguyen，H.N.，Guo，Z.，et al.Synaptic dysregulation in a human iPS cellmodel ofmental disorders［J］.Nature，2014，515：414－418.
［116］Kim，C.K.，Adhikari，A.and Deisseroth，K.Integration of optogenetics with complementary methodologies in systems neuroscience［J］.Nature Reviews Neuroscience，2017，18（4）：222.
［117］Sekar，A.，Bialas，A.R.，De，R.H.，et al.Schizophrenia risk from complex variation of complement component4［J］.Nature，2016，530：177－183.
［118］Garey，L.J.，Ong，W.Y.，Patel，T.S.，et al.Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia［J］.J Neurol Neurosurg Psychiatry，1998，65（4）：446－453.
［119］Glantz，L.A.and Lewis，D.A.Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia［J］.Archives of General Psychiatry，2000，57（1）：65.
［120］Glausier，J.R.and Lewis，D.A.Dendritic spine pathology in schizophrenia［J］.Neuroscience，2013，251（15）：90－107.
［121］Krey，J.F.，Pa Ca，S.P.，Aleksandr，S.，et al.Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons［J］.Nature Neuroscience，2013，16（2）：201－209.
［122］Jian-Ping，Z.，Todd，L.，Malhotra，A.K.D2 receptor genetic variation and clinical response to antipsychotic drug treatment：A meta-analysis［J］.American Journal of Psychiatry，2010，167（7）：763－772.
［123］Zhang，J.P.and Malhotra，A.K.Pharmacogenetics of antipsychotics：Recent progress and methodological issues［J］.Expert Opinion on Drug Metabolism＆Toxicology，2013，9（2）：183－191.
［124］Lieberman，J.A.，Yunis，J.，Egea，E.，et al.HLA-B38，DR4，DQw3 and Clozapine-induced Agranulocytosis in Jewish patients With schizophrenia［J］.Archives of General Psychiatry，1990，47（10）：945.
［125］Yunis，J.J.，Corzo，D.，Salazar，M.，et al.HLA associations in clozapine-induced agranulocytosis［J］.Blood，1995，86（3）：1177.
［126］Athanasiou，M.C.，Michael，D.，Ingolf，C.，et al.Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis［J］.Journal of Clinical Psychiatry，2010，72（4）：458－463.
［127］Zhang，J.P.and Malhotra，A.K.Pharmacogenetics and antipsychotics：Therapeutic efficacy and side effects prediction［J］.Expert Opin Drug Metab Toxicol，2011，7（1）：9－37.
［128］Riglin，L.，Collishaw，S.，Richards，A.，et al.Schizophrenia risk alleles and neurodevelopmental outcomes in childhood：A population-based cohort study［J］.Lancet Psychiatry，2017，4（1）：57.
［129］Ahn，K.，An，S.S.，Shugart，Y.Y.，et al.Common polygenic variation and risk for childhood-onset schizophrenia［J］.Mol Psychiatry，2014，21（1）：94－96.
［130］Meltzer，H.Y.Treatment-resistant schizophrenia—the role of clozapine［J］.CurrentMedical Research＆Opinion，1997，14（1）：1－20.
［131］Nielsen，J.，Nielsen，R.E.and Correll，C.U.Predictors of clozapine response in patients with treatment-refractory schizophrenia：Results from a Danish register study［J］.JClin Psychopharmacol，2012，32（5）：678－683.
［132］Frank，J.，Lang，M.，Witt，S.H.，et al.Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients［J］.Molecular Psychiatry，2014，20（2）：913.
［133］Tansey，K.E.，Rees，E.，Linden，D.E.，et al.Common alleles contribute to schizophrenia in CNV carriers［J］.Mol Psychiatry，2016，21（8）：1085－1089.
［134］Chatterjee，N.，Shi，J.and García-Closas，M.Developing and evaluating polygenic risk prediction models for stratified disease prevention［J］.Nature Reviews Genetics，2016，17（7）：392.
［135］Shadrina，M.，Bondarenko，E.A.and Slominsky，P.A.Genetics factors in major depression disease［J］.Front Psychiatry，2018，9：334.
［136］Flint，J.and Kendler，K.S.The genetics ofmajor depression［J］.Neuron，2014，81（5）：1214.
［137］Murray，C.J.and Lopez，A.D.Evidence-based health policy—lessons from the global burden of disease study［J］.Science，1996，274：740－743.
［138］Sullivan，P.F.，Neale，M.C.，Kendler，K.S.Genetic epidemiology of major depression：Review and meta-analysis［J］.Am J Psychiatry，2000，157（10）：1552－1562.(https://www.daowen.com)
［139］Mcguffin，P.，Cohen，S.and Knight，J.Homing in on depression genes［J］.Am JPsychiatry，2007，164（2）：195－197.
［140］Menke，A.，Klengel，T.and Binder，E.B.Epigenetics，depression and antidepressant treatment［J］.Curr Pharm Des，2012，18（36）：5879－5889.
［141］Kendler，K.S.，Gardner，C.O.，Neale，M.C.，et al.Genetic risk factors formajor depression in men and women：Similar or different heritabilities and same or partly distinct genes？［J］.Psychol Med，2001，31（4）：605－616.
［142］Kendler，K.S.，Gatz，M.，Gardner，C.O.，et al.A Swedish national twin study of lifetimemajor depression［J］.Am JPsychiatry，2006，163（1）：109－114.
［143］Beckman，G.，Beckman，L.，Cedergren，B.，et al.Serum protein and red cell enzyme polymorphisms in affective disorders［J］.Hum Hered，1978，28（1）：41－47.
［144］Ebmeier，K.P.，Donaghey，C.and Steele，J.D.Recent developments and current controversies in depression［J］.Lancet，2006，367：153－167.
［145］Deverteuil，R.L.and Lehmann，H.E.Therapeutic trial of iproniazid（marsilid）in depressed and apathetic patients［J］.Can Med Assoc J，1958，78（2）：131－133.
［146］Kraft，J.B.，Slager，S.L.，Mcgrath，P.J.，et al.Sequence analysis of the serotonin transporter and associations with antidepressant response［J］.Biol Psychiatry，2005，58（5）：374－381.
［147］Hu，X.Z.，Lipsky，R.H.，Zhu，G.，et al.Serotonin transporter promoter gain-offunction genotypes are linked to obsessive-compulsive disorder［J］.Am J Hum Genet，2006，78（5）：815－826.
［148］Kuhn，R.The treatment of depressive states with G 22355（imipramine hydrochloride）［J］.Am JPsychiatry，1958，115（5）：459－464.
［149］Schildkraut，J.J.and Kety，S.S.Biogenic amines and emotion［J］.Science，1967，156：21－37.
［150］Leonard，B.E.Evidence for a biochemical lesion in depression［J］.J Clin Psychiatry，2000，61（6）：12－17.
［151］Ressler，K.J.and Nemeroff，C.B.Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders［J］.Depress Anxiety，2000，12（1）：2－19.
［152］Manji，H.K.，Drevets，W.C.and Charney，D.S.The cellular neurobiology of depression［J］.Nat Med，2001，7（5）：541－547.
［153］Nutt，D.J.The neuropharmacology of serotonin and noradrenaline in depression［J］.Int Clin Psychopharmacol，2002，17（1）：S1－S12.
［154］Ramamoorthy，S.，Bauman，A.L.，Moore，K.R.，et al.Antidepressant-and cocainesensitive human serotonin transporter：Molecular cloning，expression，and chromosomal localization［J］.Proc Natl Acad Sci USA，1993，90（6）：2542－2546.
［155］Heils，A.，Teufel，A.，Petri，S.，et al.Functional promoter and polyadenylation sitemapping of the human serotonin（5-HT）transporter gene［J］.J Neural Transm Gen Sect，1995，102（3）：247－254.
［156］Lesch，K.P.，Bengel，D.，Heils，A.，et al.Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region［J］.Science，1996，274：1527－1531.
［157］Heils，A.，Teufel，A.，Petri，S.，et al.Allelic variation of human serotonin transporter gene expression［J］.JNeurochem，1996，66（6）：2621－2624.
［158］Nakamura，M.，Ueno，S.，Sano，A.，et al.The human serotonin transporter gene linked polymorphism（5-HTTLPR）shows ten novel allelic variants［J］.Mol Psychiatry，2000，5（1）：32－38.
［159］Wendland，J.R.，Martin，B.J.，Kruse，M.R.，et al.Simultaneous genotyping of four functional loci of human SLC6A4，with a reappraisal of 5-HTTLPR and rs25531［J］.Mol Psychiatry，2006，11（3）：224－226.
［160］Wendland，J.R.，Moya，P.R.，Kruse，M.R.，et al.A novel，putative gain-offunction haplotype at SLC6A4 associates with obsessive-compulsive disorder［J］.Hum Mol Genet，2008，17（5）：717－723.
［161］Mackenzie，A.and Quinn，J.A serotonin transporter gene intron 2 polymorphic region，correlated with affective disorders，has allele-dependent differential enhancer-like properties in themouse embryo［J］.Proc Natl Acad SciUSA，1999，96（26）：15251－15255.
［162］Ali，F.R.，Vasiliou，S.A.，Haddley，K.，et al.Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF［J］.JNeurochem，2010，112（1）：296－306.
［163］Baudry，A.，Mouillet-Richard，S.，Schneider，B.，et al.miR-16 targets the serotonin transporter：A new facet for adaptive responses to antidepressants［J］.Science，2010，329：1537－1541.
［164］Lopez-Leon，S.，Janssens，A.C.，Gonzalez－Zuloeta，L.A.，et al.Meta-analyses of genetic studies on major depressive disorder［J］.Mol Psychiatry，2008，13（8）：772－785.
［165］Murphy，D.L.，Maile，M.S.and Vogt，N.M.5HTTLPR：White knight or dark blight？［J］.ACSChem Neurosci，2013，4（1）：13－15.
［166］Chen，D.，Meng，L.，Pei，F.，et al.A review of DNA methylation in depression［J］.JClin Neurosci，2017，43：39－46.
［167］Wang，Q.，Timberlake，M.N.，Prall，K.，et al.The recent progress in animal models of depression［J］.Prog Neuropsychopharmacol Biol Psychiatry，2017，77：99－109.
［168］Oo，K.Z.，Aung，Y.K.，Jenkins，M.A.，et al.Associations of 5HTTLPR polymorphism withmajor depressive disorder and alcohol dependence：A systematic review and meta-analysis［J］.Aust N Z J Psychiatry，2016，50（9）：842－857.
［169］Bao，A.M.，Meynen，G.and Swaab，D.F.The stress system in depression and neurodegeneration：Focus on the human hypothalamus［J］.Brain Res Rev，2008，57（2）：531－553.
［170］Holsboer，F.The corticosteroid receptor hypothesis of depression［J］.Neuropsychopharmacology，2000，23（5）：477－501.
［171］Kendler，K.S.，Karkowski，L.M.and Prescott，C.A.Causal relationship between stressful life events and the onsetofmajor depression［J］.Am JPsychiatry，1999，156（6）：837－841.
［172］Swaab，D.F.，Bao，A.M.and Lucassen，P.J.The stress system in the human brain in depression and neurodegeneration［J］.Ageing Res Rev，2005，4（2）：141－194.
［173］Nemeroff，C.B.The corticotropin-releasing factor（CRF）hypothesis of depression：New findings and new directions［J］.Mol Psychiatry，1996，1（4）：336－342.
［174］Modell，S.，Yassouridis，A.，Huber，J.，et al.Corticosteroid receptor function is decreased in depressed patients［J］.Neuroendocrinology，1997，65（3）：216－222.
［175］Maric，N.P.and Adzic，M.Pharmacological modulation of HPA axis in depression—new avenues for potential therapeutic benefits［J］.Psychiatr Danub，2013，25（3）：299－305.
［176］Derijk，R.H.，Schaaf，M.and de Kloet，E.R.Glucocorticoid receptor variants：Clinical implications［J］.JSteroid Biochem Mol Biol，2002，81（2）：103－122.
［177］Klok，M.D.，Alt，S.R.，Irurzun，L.A.，et al.Decreased expression of mineralocorticoid receptormRNA and its splice variants in postmortem brain regions of patients with major depressive disorder［J］.J Psychiatr Res，2011，45（7）：871－878.
［178］Schatzberg，A.F.，Keller，J.，Tennakoon，L.，et al.HPA axis genetic variation，cortisol and psychosis in major depression［J］.Mol Psychiatry，2014，19（2）：220－227.
［179］Liu，Z.，Zhu，F.，Wang，G.，et al.Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype withmajor depression［J］.Neurosci Lett，2006，404（3）：358－362.
［180］Szczepankiewicz，A.，Leszczynska-Rodziewicz，A.，Pawlak，J.，et al.Epistatic interaction between CRHR1 and AVPR1b variants as a predictor ofmajor depressive disorder［J］.Psychiatr Genet，2013，23（6）：239－246.
［181］Xiao，Z.，Liu，W.，Gao，K.，et al.Interaction between CRHR1 and BDNF genes increases the risk of recurrentmajor depressive disorder in Chinese population［J］.PLoSOne，2011，6（12）：e28733.
［182］Gatt，J.M.，Burton，K.L.，Williams，L.M.，et al.Specific and common genes implicated acrossmajormental disorders：A review ofmeta-analysis studies［J］.J Psychiatr Res，2015，60：1－13.
［183］Sheline，Y.I.，Wang，P.W.，Gado，M.H.，et al.Hippocampal atrophy in recurrentmajor depression［J］.Proc Natl Acad Sci USA，1996，93（9）：3908－3913.
［184］Jacobs，B.L.，van Praag，H.，Gage，F.H.Adultbrain neurogenesis and psychiatry：A novel theory of depression［J］.Mol Psychiatry，2000，5（3）：262－269.
［185］Monteggia，L.M.，Barrot，M.，Powell，C.M.，et al.Essential role of brain-derived neurotrophic factor in adult hippocampal function［J］.Proc Natl Acad Sci USA，2004，101（29）：10827－10832.
［186］Duman，R.S.and Monteggia，L.M.A neurotrophicmodel for stress-related mood disorders［J］.Biol Psychiatry，2006，59（12）：1116－1127.
［187］Ressler，K.J.and Mayberg，H.S.Targeting abnormal neural circuits inmood and anxiety disorders：From the laboratory to the clinic［J］.Nat Neurosci，2007，10（9）：1116－1124.
［188］Mckinnon，M.C.，Yucel，K.，Nazarov，A.，et al.A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder［J］.JPsychiatry Neurosci，2009，34（1）：41－54.
［189］Cobb，J.A.，Simpson，J.，Mahajan，G.J.，et al.Hippocampal volume and total cell numbers in major depressive disorder［J］.J Psychiatr Res，2013，47（3）：299－306.
［190］Gorski，J.A.，Zeiler，S.R.，Tamowski，S.，et al.Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites［J］.J Neurosci，2003，23（17）：6856－6865.
［191］Martinowich，K.and Lu，B.Interaction between BDNF and serotonin：Role in mood disorders［J］.Neuropsychopharmacology，2008，33（1）：73－83.
［192］Schecterson，L.C.，Sanchez，J.T.，Rubel，E.W.，et al.TrkB downregulation is required for dendrite retraction in developing neurons of chicken nucleus magnocellularis［J］.JNeurosci，2012，32（40）：14000－14009.
［193］Chen，Z.Y.，Patel，P.D.，Sant，G.，et al.Variant brain-derived neurotrophic factor（BDNF）（Met66）alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons［J］.J Neurosci，2004，24（18）：4401－4411.
［194］Gabriele，B.，Davide，C.，Lucia，G.，et al.Toward a unified biological hypothesis for the BDNF Val66Met-associatedmemory deficits in humans：A model of impaired dendriticmRNA trafficking［J］.Frontiers in Neuroscience，2013，7：188.
［195］Verhagen，M.，van der Meij，A.，van Deurzen，P.A.，et al.Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder：Effects of gender and ethnicity［J］.Mol Psychiatry，2010，15（3）：260－271.
［196］Schumacher，J.，Jamra，R.A.，Becker，T.，et al.Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor（BDNF）locus and major depression［J］.Biol Psychiatry，2005，58（4）：307－314.
［197］Ribeiro，L.，Busnello，J.V.，Cantor，R.M.，et al.The brain-derived neurotrophic factor rs6265（Val66Met）polymorphism and depression in Mexican-Americans［J］.Neuroreport，2007，18（12）：1291－1293.
［198］Frielingsdorf，H.，Bath，K.G.，Soliman，F.，et al.Variant brain-derived neurotrophic factor Val66Met endophenotypes：Implications for posttraumatic stress disorder［J］.Ann N Y Acad Sci，2010，1208：150－157.
［199］Liu，X.，Xu，Y.，Jiang，S.，et al.Family-based association study between brainderived neurotrophic factor gene and major depressive disorder of Chinese descent［J］.Psychiatry Res，2009，169（2）：169－172.
［200］Kaufman，J.，Yang，B.Z.，Douglas-Palumberi，H.，et al.Brain-derived neurotrophic factor—5-HTTLPR gene interactions and environmental modifiers of depression in children［J］.Biol Psychiatry，2006，59（8）：673－680.
［201］Pezawas，L.，Meyer-Lindenberg，A.，Goldman，A.L.，et al.Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression［J］.Mol Psychiatry，2008，13（7）：709－716.
［202］Maes，M.Major depression and activation of the inflammatory response system［J］.Adv Exp Med Biol，1999（461）：25－46.
［203］Wohleb，E.S.，Mckim，D.B.，Sheridan，J.F.，et al.Monocyte trafficking to the brain with stress and inflammation：A novel axis of immune-to-brain communication that influencesmood and behavior［J］.Front Neurosci，2014，8：447.
［204］Hodes，G.E.，Kana，V.，Menard，C.，et al.Neuroimmune mechanisms of depression［J］.Nature Neuroscience，2015，18（10）：1386.
［205］Dowlati，Y.，Herrmann，N.，Swardfager，W.，et al.A meta-analysis of cytokines inmajor depression［J］.Biol Psychiatry，2010，67（5）：446－457.
［206］Meyers，C.A.，Albitar，M.and Estey，E.Cognitive impairment，fatigue，and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome［J］.Cancer，2010，104（4）：788－793.
［207］Motivala Sj，S.A.O.L.Inflammatory markers and sleep disturbance in major depression［J］.Psychosom Med.，2005（67）：187－194.
［208］Irwin，M.R.，Wang，M.，Ribeiro，D.，et al.Sleep loss activates cellular inflammatory signaling［J］.Biological Psychiatry，2008，64（6）：538－540.
［209］Loftis，J.M.and Hauser，P.The phenomenology and treatment of interferoninduced depression［J］.Journal of Affective Disorders，2004，82（2）：175－190.
［210］Asnis，G.M.and De La Garza，R.Interferon-induced depression in chronic hepatitis C：A review of its prevalence，risk factors，biology，and treatment approaches［J］.Journal of Clinical Gastroenterology，2006，40（4）：322－335.
［211］Mcculley，M.C.，Day，I.N.，Holmes，C.Association between interleukin 1-β promoter（－511）polymorphism and depressive symptoms in Alzheimer's disease［J］.American Journal of Medical Genetics Part B：Neuropsychiatric Genetics，2004，124（1）：50－53.
［212］Borkowska，P.，Kucia，K.，Rzezniczek，S.，et al.Interleukin-1beta promoter（－31T／C and－511C／T）polymorphisms inmajor recurrent depression［J］.Journal of Molecular Neuroscience，2011，44（1）：12－16.
［213］Younger，W.Y.，Chen，T.，Hong，C.，et al.Association study of the interleukin-1beta（C-511T）genetic polymorphism with major depressive disorder，associated symptomatology，and antidepressant response［J］.Neuropsychopharmacology，2003，28（6）：1182.
［214］Tadic＇ ，A.，Rujescu，D.，Müller，M.J.，et al.Association analysis between variants of the interleukin-1βand the interleukin-1 receptor antagonist gene and antidepressant treatment response inmajor depression［J］.Neuropsychiatric Disease and Treatment，2008，4（1）：269.
［215］Hwang，J.，Tsai，S.，Hong，C.，et al.Interleukin-1 beta－511C／T genetic polymorphism is associated with age of onset of geriatric depression［J］.Neuromolecular Medicine，2009，11（4）：322.
［216］Chen，H.，Wilkins，L.M.，Aziz，N.，et al.Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context［J］.Human Molecular Genetics，2006，15（4）：519－529.
［217］Hwang，I.，Kodama，T.，Kikuchi，S.，et al.Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1βproduction in Helicobacter pylori infection［J］.Gastroenterology，2002，123（6）：1793－1803.
［218］Hall，S.K.，Perregaux，D.G.，Gabel，C.A.，et al.Correlation of polymorphic variation in the promoter region of the interleukin-1β gene with secretion of interleukin-1β protein［J］.Arthritis＆Rheumatism：Official Journal of the American College of Rheumatology，2004，50（6）：1976－1983.
［219］Fishman，D.，Faulds，G.，Jeffery，R.，et al.The effect of novel polymorphisms in the interleukin-6（IL-6）gene on IL-6 transcription and plasma IL-6 levels，and an association with systemic-onset juvenile chronic arthritis［J］.The Journal of Clinical Investigation，1998，102（7）：1369－1376.
［220］Hong，C.，Yu，Y.W.，Chen，T.，et al.Interleukin-6 genetic polymorphism and Chinesemajor depression［J］.Neuropsychobiology，2005，52（4）：202－205.
［221］Misener，V.L.，Gomez，L.，Wigg，K.G.，et al.Cytokine Genes TNF，IL1A，IL1B，IL6，IL1RN and IL10，and childhood-onset mood disorders［J］.Neuropsychobiology，2008，58（2）：71－80.
［222］Clerici，M.，Arosio，B.，Mundo，E.，et al.Cytokine polymorphisms in the pathophysiology ofmood disorders［J］.CNSSpectrums，2009，14（8）：419－425.
［223］Bull，S.J.，Huezo-Diaz，P.，Binder，E.B.，et al.Functional polymorphisms in the interleukin-6 and serotonin transporter genes，and depression and fatigue induced by interferon-αand ribavirin treatment［J］.Molecular Psychiatry，2009，14（12）：1095.
［224］Weaver，D.R.The suprachiasmatic nucleus：A 25-year retrospective［J］.Journal of Biological Rhythms，1998，13（2）：100－112.
［225］Albrecht，U.Timing to perfection：The biology of central and peripheral circadian clocks［J］.Neuron，2012，74（2）：246－260.
［226］Takahashi，J.S.，Hong，H.，Ko，C.H.，et al.The genetics of mammalian circadian order and disorder：Implications for physiology and disease［J］.Nature Reviews Genetics，2008，9（10）：764.
［227］Reischl，S.and Kramer，A.Kinases and phosphatases in themammalian circadian clock［J］.FEBSLetters，2011，585（10）：1393－1399.
［228］Armitage，R.Sleep and circadian rhythms in mood disorders［J］.Acta Psychiatrica Scandinavica，2007，115：104－115.
［229］Gallego，M.and Virshup，D.M.Post-translational modifications regulate the ticking of the circadian clock［J］.Nature ReviewsMolecular Cell Biology，2007，8（2）：139.
［230］Gouin，J.，Connors，J.，Kiecolt-Glaser，J.K.，et al.Altered expression of circadian rhythm genes among individuals with a history of depression［J］.Journal of Affective Disorders，2010，126（1－2）：161－166.
［231］Kishi，T.，Yoshimura，R.，Fukuo，Y.，et al.The CLOCK gene and mood disorders：A case-control study and meta-analysis［J］.Chronobiology International，2011，28（9）：825－833.
［232］Holmans，P.，Zubenko，G.S.，Crowe，R.R.，et al.Genomewide significant linkage to recurrent，early-onset major depressive disorder on chromosome 15q［J］.The American Journal of Human Genetics，2004，74（6）：1154－1167.
［233］Abkevich，V.，Camp，N.J.，Hensel，C.H.，et al.Predisposition locus formajor depression at chromosome 12q22－12q23.2［J］.The American Journal of Human Genetics，2003，73（6）：1271－1281.
［234］Camp，N.J.，Lowry，M.R.，Richards，R.L.，et al.Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent，earlyonsetmajor depression and anxiety disorders［J］.American Journal of Medical Genetics Part B：Neuropsychiatric Genetics，2005，135（1）：85－93.
［235］Mcguffin，P.，Knight，J.，Breen，G.，et al.Whole genome linkage scan of recurrent depressive disorder from the depression network study［J］.Human Molecular Genetics，2005，14（22）：3337－3345.
［236］Middeldorp，C.M.，Sullivan，P.F.，Wray，N.R.，et al.Suggestive linkage on chromosome 2，8，and 17 for lifetime major depression［J］.American Journal of Medical Genetics Part B：Neuropsychiatric Genetics，2009，150（3）：352－358.
［237］Sullivan，P.F.，de Geus，E.J.，Willemsen，G.，et al.Genome-wide association for major depressive disorder：A possible role for the presynaptic protein piccolo［J］.Mol Psychiatry，2009，14（4）：359－375.
［238］Muglia，P.，Tozzi，F.，Galwey，N.W.，et al.Genome-wide association study of recurrentmajor depressive disorder in two European case-control cohorts［J］.Mol Psychiatry，2010，15（6）：589－601.
［239］Lewis，C.M.，Ng，M.Y.，Butler，A.W.，et al.Genome-wide association study of major recurrent depression in the U.K.population［J］.Am J Psychiatry，2010，167（8）：949－957.
［240］Rietschel，M.，Mattheisen，M.，Frank，J.，et al.Genome-wide association-，replication-，and neuroimaging study implicates HOMER1 in the etiology ofmajor depression［J］.Biological Psychiatry，2010，68（6）：578－585.
［241］Shi，J.，Potash，J.B.，Knowles，J.A.，et al.Genome-wide association study of recurrent early-onset major depressive disorder［J］.Mol Psychiatry，2011，16（2）：193－201.
［242］Shyn，S.I.，Shi，J.，Kraft，J.B.，et al.Novel loci formajor depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies［J］.Molecular Psychiatry，2011，16（2）：202.
［243］Kohli，M.A.，Lucae，S.，Saemann，P.G.，et al.The neuronal transporter gene SLC6A15 confers risk tomajor depression［J］.Neuron，2011，70（2）：252－265.
［244］Aragam，N.，Wang，K.，Pan，Y.Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples［J］.Journal of Affective Disorders，2011，133（3）：516－521.
［245］Wray，N.R.，Pergadia，M.L.，Blackwood，D.，et al.Genome-wide association study ofmajor depressive disorder：New results，meta-analysis，and lessons learned［J］.Molecular Psychiatry，2012，17（1）：36.
［246］Hek，K.，Demirkan，A.，Lahti，J.，et al.A genome-wide association study of depressive symptoms［J］.Biological Psychiatry，2013，73（7）：667－678.
［247］Power，R.A.，Cohen Woods，S.，Ng，M.Y.，et al.Genome-wide association analysis accounting for environmental factors through propensity-scorematching：Application to stressful live events in major depressive disorder［J］.American Journal of Medical Genetics Part B：Neuropsychiatric Genetics，2013，162（6）：521－529.
［248］Ikeda，M.，Shimasaki，A.，Takahashi，A.，et al.Genome-wide environment interaction between depressive state and stressful life events［J］.The Journal of Clinical Psychiatry，2016，77（1）：e29.
［249］Okbay，A.，Baselmans，B.M.，De Neve，J.，et al.Genetic variants associated with subjective well-being，depressive symptoms，and neuroticism identified through genome-wide analyses［J］.Nature Genetics，2016，48（6）：624.
［250］Matsunami，K.，Nishida，N.，Kaneko，N.，et al.Genome-wide association study identifies ZNF354C variants associated with depression from interferon-based therapy for chronic hepatitis C［J］.PLoSOne，2016，11（10）：e164418.
［251］Direk，N.，Williams，S.，Smith，J.A.，et al.An analysis of two genome-wide association meta-analyses identifies a new locus for broad depression phenotype［J］.Biological Psychiatry，2017，82（5）：322－329.
［252］Wray，N.R.，Ripke，S.，Mattheisen，M.，et al.Genome-wide association analyses identify 44 risk variants and refine the genetic architecture ofmajor depression［J］.Nature Genetics，2018，50（5）：668.
［253］Sullivan，P.F.，de Geus，E.J.，Willemsen，G.，et al.Genome-wide association for major depressive disorder：A possible role for the presynaptic protein piccolo［J］.Molecular Psychiatry，2009，14（4）：359.
［254］Ripke，S.，Wray，N.R.，Lewis，C.M.，et al.A mega-analysis of genome-wide association studies formajor depressive disorder［J］.Molecular Psychiatry，2013，18（4）：497.
［255］Sebat，J.，Lakshmi，B.，Malhotra，D.，et al.Strong association of de novo copy numbermutations with autism［J］.Science，2007，316：445－449.
［256］Purcell，S.M.，Moran，J.L.，Fromer，M.，et al.A polygenic burden of rare disruptivemutations in schizophrenia［J］.Nature，2014，506：185.
［257］Cai，N.，Bigdeli，T.B.，Kretzschmar，W.，et al.Sparse whole-genome sequencing identifies two loci formajor depressive disorder［J］.Nature，2015，523：588.
［258］Peterson，R.E.，Cai，N.，Bigdeli，T.B.，et al.The genetic architecture ofmajor depressive disorder in Han Chinese women［J］.JAMAPsychiatry，2017，74（2）：162－168.
［259］Docherty，A.R.，Edwards，A.C.，Yang，F.，et al.Age of onset and family history as indicators of polygenic risk for major depression［J］.Depression and Anxiety，2017，34（5）：446－452.
［260］Bigdeli，T.B.，Ripke，S.，Peterson，R.E.，et al.Genetic effects influencing risk formajor depressive disorder in China and Europe［J］.Translational Psychiatry，2017，7（3）：e1074.
［261］Purcell，S.M.，Wray，N.R.，Stone，J.L.，et al.Common polygenic variation contributes to risk of schizophrenia and bipolar disorder［J］.Nature，2009，460：748－752.
［262］Song，G.G.，Kim，J.，Lee，Y.H.Genome-wide pathway analysis in major depressive disorder［J］.Journal ofMolecular Neuroscience，2013，51（2）：428－436.
［263］Hyde，C.L.，Nagle，M.W.，Tian，C.，et al.Identification of 15 genetic loci associated with risk of major depression in individuals of European descent［J］.Nature Genetics，2016，48（9）：1031.
［264］W ray，N.R.，Ripke，S.，Mattheisen，M.，et al.Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression［J］.Nat Genet，2018，50：668－681.
［265］Wang，C.，Dai，J.，Sun，Y.，et al.Genetic risk score：Principle，methods and application［J］.Zhonghua Liuxingbingxue Zazhi，2015，36（10）：1062－1064.
［266］Dudbridge，F.Power and predictive accuracy of polygenic risk scores［J］.PLoS Genetics，2013，9（3）：e1003348.
［267］Peyrot，W.J.，Milaneschi，Y.，Abdellaoui，A.，et al.Effect of polygenic risk scores on depression in childhood trauma［J］.The British Journal of Psychiatry，2014，205（2）：113－119.
［268］Whalley，H.C.，Adams，M.J.，Hall，L.S.，et al.Dissection ofmajor depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts［J］.Translational Psychiatry，2016，6（11）：e938.
［269］Wang，T.，Zhang，X.，Li，A.，et al.Polygenic risk for five psychiatric disorders and cross-disorder and disorder-specific neural connectivity in two independent populations［J］.NeuroImage：Clinical，2017，14：441－449.
［270］Smoller，J.W.，Craddock，N.，Kendler，K.，et al.Identification of risk lociwith shared effects on five major psychiatric disorders：A genome-wide analysis［J］.Lancet，2013，381：1371－1379.
［271］Lee，S.H.，Ripke，S.，Neale，B.M.，et al.Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs［J］.Nat Genet，2013，45（9）：984－994.
［272］Bearden，C.E.，Reus，V.I.，Freimer，N.B.Why genetic investigation of psychiatric disorders is so difficult［J］.Curr Opin Genet Dev，2004，14（3）：280－286.
［273］Burmeister，M.，Mcinnis，M.G.and Zollner，S.Psychiatric genetics：Progress amid controversy［J］.Nat Rev Genet，2008，9（7）：527－540.
［274］Becker，K.G.The common variants／multiple disease hypothesis of common complex genetic disorders［J］.Med Hypotheses，2004，62（2）：309－317.
［275］曾真.DGKH、FGFR2基因在精神分裂症、双向情感障碍和重度抑郁症中的共享风险分析及NOS3基因与糖尿病肾病的荟萃分析［D］.上海：上海交通大学，2010.